Spring Break
The Daily OrangeNews
13 degrees of the Student Association
Meet the new cabinet of the 51st session
By Caitlin Hogan
Once considered Student Association President Ryan Kelly's protégé, Mike Rizzolo is only one degree removed from Kelly: Rizzolo lives in Watson 2 East with the same residence advisor whom Kelly had when he lived there his sophomore year. Elected by the student body, Rizzolo is eligible to vote on the Cabinet and during tie breaking votes on the Financial Board, but not in the assembly.
O.A.R. to perform March 1
By Paige Dearing
University Union Concerts announced Saturday that Of a Revolution, more commonly known as O.A.R., will play March 1 in downtown Syracuse at the Landmark Theatre. Students and Syracuse University faculty can buy tickets starting Wednesday for $13 with valid identification.
All in a life's work
Former professor, design consultant dies at 93
By Erin Curran
Edmund C. Arnold, typographer, educator, author and trailblazer, who elevated the importance of visual journalism, died Feb. 2 at Lewis-Gale Hospital in Roanoke, Va. He was 93. During his career, Arnold rose to prominence as the "father of modern newspaper design," transforming newspapers across the United States and Canada by helping them adopt more modern and readable formats.
Smokers be warned: Marijuana can become addictive for abusers
By Frank Ready
Many college students are not strangers to marijuana use. Contrary to common belief, a recent study has found marijuana users can become dependent on the illegal drug. The use of marijuana, psychedelic drugs and alcohol is higher on college campuses than anywhere else, said Dessa Bergen-Cico, a senior part-time instructor in the College of Human Services and Health Professions and a specialist in drug abuse prevention and research.
Weight loss pill moves to shelves
By Brian Hayden
Despite side effects that may increase the use of Pepto-Bismol across the country, a diet pill will be the first of its kind to hit the over-the-counter weight loss market this summer. Alli, a product of pharmaceutical giant GlaxoSmithKline, was approved last week by the Food and Drug Administration for over-the-counter sale.
